首页> 美国卫生研究院文献>The Journal of Experimental Medicine >COMPARISON OF THE POTENCY OF POLYVALENT ANTIMENINGOCOCCUS SERUM PRODUCED WITH FOUR AND SIX REPRESENTATIVE STRAINS AND THAT PRODUCED WITH SIXTY STRAINS AS DETERMINED BY THE AGGLUTINATION TITER
【2h】

COMPARISON OF THE POTENCY OF POLYVALENT ANTIMENINGOCOCCUS SERUM PRODUCED WITH FOUR AND SIX REPRESENTATIVE STRAINS AND THAT PRODUCED WITH SIXTY STRAINS AS DETERMINED BY THE AGGLUTINATION TITER

机译:凝集滴定法测定四种和六种代表性菌株与六十种菌株产生的多价羊膜炎球菌血清的强度比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The potency of a polyvalent antimeningococcus serum, as tested by its agglutination titer, was sacrificed by immunization with a large number of strains of the meningococcus. By immunization with a limited number of representative strains, four or six, carefully selected on account of their antigenic and agglutination properties, the potency was increased three- to tenfold without sacrificing the polyvalency; that is, as tested with at least 70 heterologous strains of the meningococcus. The agglutination titer, unfortunately, is not an entirely satisfactory criterion of therapeutic potency, but it is the only practical method available that determines also the polyvalent action of antimeningococcus serum.
机译:通过凝集滴度测试的多价抗脑膜炎球菌血清的效力是通过用大量脑膜炎球菌菌株免疫而牺牲的。通过有限数量的代表性菌株(四或六种)的免疫接种,这些菌株根据其抗原性和凝集特性进行了精心选择,在不影响多价的情况下,其效价提高了三倍至十倍。也就是说,用至少70个脑膜炎球菌异源菌株进行了测试。不幸的是,凝集滴度不是治疗效果的完全令人满意的标准,但它是唯一可确定抗脑膜炎双球菌血清多价作用的实用方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号